Skip to main content
. 2016 Oct 18;68(16):1769–1780. doi: 10.1016/j.jacc.2016.07.768

Table 5.

MACE

MACE Placebo Canakinumab p Value
Group
 All
 N 94 95
Yes 7 (7) 10 (11) 0.612
No 87 (93) 85 (89)
Type 2 diabetes mellitus
 N 81 81
Yes 6 (7) 9 (11) 0.589
No 75 (93) 72 (89)
Impaired glucose tolerance
 N 13 14
Yes 1 (8) 1 (7) 1.000
No 12 (92) 13 (93)

Values are n (%) unless otherwise indicated.

MACE = major adverse cardiac events.